78 episodes
Illumina Genomics Podcast Illumina, Inc.
-
- Science
-
-
4.7 • 68 Ratings
-
Hear directly from the people whose work in genomics is shaping the way we think about science and our world. Listen as leading scientists discuss the impact of genomics with the Illumina Scientific Affairs team. Download or subscribe to our recurring podcasts.
-
Liquid biopsy NGS in cancer care
Pashtoon Kasi, MD, MS, explains how liquid biopsy next-generation sequencing (NGS)-based testing can benefit cancer patients. Dr. Kasi presents four colorectal cancer patient cases for whom comprehensive genomic profiling (CGP) was done via liquid biopsy and results for clinically-relevant biomarkers were obtained in 7-8 days.
-
Genetic counselling in an era of prenatal screening, tools to support patient informed consent
Listen to Genetic Counsellors Katie Ellis and Patricia Winters, Illumina discuss how more resource-efficient counselling methods are needed to support patient informed consent for genetic testing during pregnancy. They discuss the resources available for healthcare providers and expectant parents that allows them to make informed decisions.
-
Testing for NTRK Fusions
Vivek Subbiah, MD, explains how patients with rare and common tumors can benefit from next generation sequencing (NGS)-based testing for NTRK gene fusions. He presents the case of a patient who benefited from precision medicine based on the detection of a NTRK1 fusion by comprehensive genomic profiling.
-
Homologous Recombination Deficiency (HRD) Testing in Ovarian Cancer
Isabelle Ray-Coquard, MD, PhD, explains how comprehensive genomic profiling (CGP) simultaneously provides HRD and BRCA status in ovarian cancer patients. She presents the case of a patient who benefited from CGP testing for these biomarkers and shares the recent findings of the PAOLA-1 trial.
-
Pharmacogenomics: Barriers and Opportunities to Implementation
Dr. Ronald Leopold discusses implementation of pharmacogenomic screening in the healthcare industry. The conversation explores barriers to pharmacogenomic (PGx) program adoption, the future of precision medicine, and a paradigm shift away from reimbursement to value-based healthcare.
-
The Impact of Pharmacogenomics on Precision Medicine
Why does a medication effectively “cure” one patient while having little to no effect, or worse, an adverse effect, on another? The answer may be found in our genome. Pharmacogenomics research aims to understand how genetic variations affect responses to medications, and can provide vital information for physicians as they choose a therapy regimen and prescribe dosage. Dr. Howard McLeod shares his thoughts on pharmacogenomics and the future of precision medicine.
Customer Reviews
Fantastic podcast
I love this podcast. It brings genomic breakthrough science to life and makes it approachable to the public.
Well done and informative!
I am a Sr clinical scientist in a molecular diagnostics oncology laboratory and I LOVE podcasts. This is the best podcast, in my opinion, on the topic of genomics (my favorite followed by true crime and personal finance!) Dr. Bromann at Illumina is doing a great job keeping it interesting, relatable, and bringing on really accomplished guests who share their work and stories.
If you have an interest in healthcare and genomics, I highly recommend!